Skin and Connective Tissue Diseases

445 trials 165 recruiting

Filter these 445 trials by phase, country and sponsor.

Open in Search →

BBT001 in Healthy Volunteers and in Adult Patients with Atopic Dermatitis Pending

2025-522918-23-00 Atopic Dermatitis 1
Mitochondrial network modulation approach using hyperbaric oxygen (HBO) therapy and NNbUVB for treating vitiligo Pending

2025-524709-34-00 Vitiligo 4
Comparing intraoperative indocyanine green fluorescence imaging with standard clinical assessment for flap perfusion in head and neck recons… Pending

2025-524710-29-00 Head and neck cancer 6
Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria. Pending

2024-518786-10-01 Moderate to Severe Chronic Spontaneous Urticaria 4
Severe Erythema Multiforme - CORTICO Pending

2024-516018-39-00 Erythema multiforme (EM) in its severe form managed at 5
Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® Pending

2024-518307-22-01 Surgical wound infection/dehiscence caused by S. aureus 7
A Study to Learn About the Study Medicine Called PF-08049820 in People With Eczema, an Itchy Skin Rash Pending

2025-522965-31-00 Atopic Dermatitis 4
Head-to-head comparison of six different botox products voor glabellar frown wrinkles. Pending

2024-516865-35-01 Glabellar frown rhytides (wrinkles). 6
Pilot Study - Safety and Efficacy of Dalbavancin in Early Outpatient Treatment of Erysipelas and Limited Cellulitis Pending

2025-524877-18-00 Acute bacterial skin and skin structure infection (ABSS 6
NEurotrophins Mimetic compound for the treatment of diabetic foot UlcerS Pending

2024-519405-35-00 Diabetic Foot Ulcer 7
A Randomized, Placebo-controlled, Parallel Phase 2a Dose-ranging Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-0… Pending

2025-523058-16-00 Skin Toxicities Associated with Epidermal Growth Factor 4
Single-centre, randomised, double-blind, split-face comparative design clinical trial to evaluate the efficacy and safety of the topical for… Pending

2025-521806-16-00 facial melasma 7
DERMOS study : Influence of dermocorticoids on bone mineral density in patients with bullous pemphigoid. Pending

2024-515676-12-00 Bullous pemphigoid 6
IJAMP-Trial Pending

2025-523131-19-00 prick test-induced itch 6
ADfind Pending

2025-521833-97-00 Moderate-to-severe atopic dermatitis 6
A Phase IIa Trial Evaluating the Efficacy of anti-CD19 Chimeric Antigen Receptor Engineered T-Cells in Patients With Systemic Sclerosis (SSc… Pending

2024-519511-33-00 Patients will be included with a stable but active dise 4
Phase I clinical trial evaluating the safety, tolerability, and absorption of a topical product containing latanoprost acid in healthy parti… Pending

2025-522468-34-00 Androgenetic alopecia 3
Treatment of frontal fibrosing alopecia with microneedling and photodynamic therapy Pending

2023-506974-11-00 Frontal fibrosing alopecia (FFA) 4
BOOSTERS - BiOlogics in FOlliculitis decalvanS : an adaptaTivE tRial reSearch Pending

2024-514848-88-00 Folliculitis decalvans 4
Botulinum toxin injection after sternotomies to improve scar aspect and impact Pending

2025-521290-14-00 Surgery with sternotomy 5
TAR-0520 gel in Hand and Foot Syndrome Pending

2025-524008-32-00 Capecitabine-induced hand and foot syndrome 4
Lenalidomide versus methotrexate in difficult-to-treat cutaneous lupus erythematosus Pending

2024-520089-70-00 Cutaneous lupus erythematosus 5
MAINRITSys : Rituximab vs placebo for maintenance in systemic sclerosis – interstitial lung disease Pending

2025-521331-36-00 Patient with stabilized SSc-ILD (as defined by a declin 10
NEOSTART Study - NEOADJUVANT PEMBROLIZUMAB IN PATIENTS WITH HIGH RISK, STAGE IIB/IIC CUTANEOUS MELANOMA: A SINGLE ARM PROOF OF CONCEPT PHASE… Pending

2024-519573-19-00 melanoma 4